Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH logo National Institutes of Health

More Center News

Working Together at Rare Disease Day at NIH

Rare Disease Day at NIH, held this year on Feb. 28, exemplifies NCATS’ approach to rare diseases research: involving patients as partners throughout the translational research process to ensure that research and interventions address patients’ needs.

Register now for the RE(ACT) Congress America

On May 8-11, 2019, NCATS will jointly host an international rare diseases research event that will bring together leading scientific experts, patients and advocates to discuss topics, such as gene therapy, gene and cell editing, and more.

Collaborate with NCATS Scientists on the NIH HEAL InitiativeSM

NCATS welcomes HEAL-related proposals to advance promising compounds and human cell-based models through preclinical development in collaboration with NCATS’ intramural scientists.

Taking Stock and Action in the Opioid Crisis

In February, NCATS co-hosted a two-day symposium for pain and addiction researchers as part of the NIH HEAL (Helping to End Addiction Long-termSM) Initiative.

NCATS Assay on Top 10 Scientific Achievements List

A scientific society honored NCATS scientists for creating a screening test to identify molecules that block the growth of new blood vessels. The test could be useful in cancer research.

Understanding Out-of-Control Inflammation

Scientists at Brigham and Women’s Hospital collaborated with NCATS high-throughput screening experts to develop a different approach against inflammation, identifying four compounds that can potentially turn on anti-inflammatory activity.

Opioids Increase the Risk of Pneumonia

NIH-supported research suggests a new danger associated with opioids: They can increase a person’s risk for pneumonia that is severe enough to warrant hospitalization.

Natural Products Resource Could Help Researchers Find New Treatments

Canvass, a screening library for natural products, was created by NCATS to uncover the potential medical use of these compounds and enable the creation of new treatments for diseases.

NCATS Support Enables a Promising Therapy to Enter Clinical Trials

A Small Business Innovation Research award has enabled Recursion Pharmaceuticals to advance a potential treatment for a rare disease into clinical testing.

Director's Corner

Christopher P. Austin, M.D.

April Director's Message

Early in my career, I was privileged to work in an Indian Health Service hospital in Kotzebue, Alaska, that was responsible for the care of the approximately 5,000 people living in the northwest 30,000 square miles of the state.

Christopher P. Austin, M.D.

In the Spotlight

Clinical and Translational Science Awards Program

Table of Funded Activities 2014 - 2018 (PDF - 121KB)

Apply Now for the ASPIRE Design Challenges

ASPIRE Design challenges badgesThe NCATS ASPIRE Design Challenges are designed to advance innovative and catalytic approaches towards solving the opioid crisis by developing “A Specialized Platform for Innovative Research Exploration” (ASPIRE) to aid in the discovery and development of novel and effective treatments, while at the same time making the process faster and more cost-effective.  The NCATS ASPIRE Design Challenges are part of the of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. Learn more about the ASPIRE Design Challenges